Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $233.9 million.

  • Collegium Pharmaceutical's Receivables - Net rose 240.44% to $233.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $233.9 million, marking a year-over-year increase of 240.44%. This contributed to the annual value of $228.5 million for FY2024, which is 2730.26% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Receivables - Net stood at $233.9 million for Q3 2025, which was up 240.44% from $213.0 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Receivables - Net ranged from a high of $233.9 million in Q3 2025 and a low of $90.1 million during Q2 2021
  • For the 5-year period, Collegium Pharmaceutical's Receivables - Net averaged around $177.9 million, with its median value being $181.9 million (2023).
  • Per our database at Business Quant, Collegium Pharmaceutical's Receivables - Net surged by 11921.13% in 2022 and then tumbled by 1520.27% in 2023.
  • Over the past 5 years, Collegium Pharmaceutical's Receivables - Net (Quarter) stood at $105.8 million in 2021, then surged by 73.01% to $183.1 million in 2022, then fell by 1.96% to $179.5 million in 2023, then grew by 27.3% to $228.5 million in 2024, then grew by 2.37% to $233.9 million in 2025.
  • Its Receivables - Net stands at $233.9 million for Q3 2025, versus $213.0 million for Q2 2025 and $228.7 million for Q1 2025.